AAAAAA

   
Results: 1-18 |
Results: 18
T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION AS POSTREMISSION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA - FREEDOM FROM RELAPSE IN THE ABSENCE OF GRAFT-VERSUS-HOST DISEASE
Authors: PAPADOPOULOS EB CARABASI MH CASTROMALASPINA H CHILDS BH MACKINNON S BOULAD F GILLIO AP KERNAN NA SMALL TN SZABOLCS P TAYLOR J YAHALOM J COLLINS NH BLEAU SA BLACK PM HELLER G OREILLY RJ YOUNG JW
Citation: Eb. Papadopoulos et al., T-CELL-DEPLETED ALLOGENEIC BONE-MARROW TRANSPLANTATION AS POSTREMISSION THERAPY FOR ACUTE MYELOGENOUS LEUKEMIA - FREEDOM FROM RELAPSE IN THE ABSENCE OF GRAFT-VERSUS-HOST DISEASE, Blood, 91(3), 1998, pp. 1083-1090
A NOVEL GENE-THERAPY STRATEGY FOR ELIMINATION OF PROSTATE CARCINOMA-CELLS FROM HUMAN BONE-MARROW
Authors: KIM MH WRIGHT M DESHANE J ACCAVITTI MA TILDEN A SALEH M VAUGHAN WP CARABASI MH ROGERS MD HOCKETT RD GRIZZLE WE CURIEL DT
Citation: Mh. Kim et al., A NOVEL GENE-THERAPY STRATEGY FOR ELIMINATION OF PROSTATE CARCINOMA-CELLS FROM HUMAN BONE-MARROW, Human gene therapy, 8(2), 1997, pp. 157-170
IMPROVED OUTCOME IN RECIPIENTS OF HLA IDENTICAL T-CELL DEPLETED ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS CONTAINING HIGH-DOSES OF STEM-CELLS
Authors: MATTAR B CARABASI MH TILDEN AB SALZMAN D MARTIN B KUNKEL L VAUGHAN WP
Citation: B. Mattar et al., IMPROVED OUTCOME IN RECIPIENTS OF HLA IDENTICAL T-CELL DEPLETED ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS CONTAINING HIGH-DOSES OF STEM-CELLS, Blood, 90(10), 1997, pp. 4421-4421
IMPROVED PROGRESSION FREE AND OVERALL SURVIVAL IN RELAPSED NON-HODGKIN-LYMPHOMA (NHL) TREATED WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) USING A BUSULFAN BASED PREPARATIVE REGIMEN
Authors: MEEKS MC TILDEN A SALZMAN DE CARABASI MH VAUGHAN WP
Citation: Mc. Meeks et al., IMPROVED PROGRESSION FREE AND OVERALL SURVIVAL IN RELAPSED NON-HODGKIN-LYMPHOMA (NHL) TREATED WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) USING A BUSULFAN BASED PREPARATIVE REGIMEN, Blood, 90(10), 1997, pp. 4567-4567
RAPID IMMUNE RECONSTITUTION IN RECIPIENTS OF T-CELL DEPLETED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS FROM ALA IDENTICAL SIBLINGS
Authors: CARABASI MH TILDEN AB SHRESTRA K SALZMAN D MARTIN B VAUGHAN WP KUNKEL L BUCY RP
Citation: Mh. Carabasi et al., RAPID IMMUNE RECONSTITUTION IN RECIPIENTS OF T-CELL DEPLETED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTS FROM ALA IDENTICAL SIBLINGS, Blood, 90(10), 1997, pp. 2415-2415
RESOLUTION OF MIRIZZIS-SYNDROME USING ENDOSCOPIC THERAPY
Authors: BARON TH SCHROEDER PL SCHWARTZBERG MS CARABASI MH
Citation: Th. Baron et al., RESOLUTION OF MIRIZZIS-SYNDROME USING ENDOSCOPIC THERAPY, Gastrointestinal endoscopy, 44(3), 1996, pp. 343-345
ADOPTIVE IMMUNOTHERAPY USING DONOR LEUKOCYTES FOLLOWING BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - IS T-CELL DOSE IMPORTANTIN DETERMINING BIOLOGICAL RESPONSE
Authors: MACKINNON S PAPADOPOULOS EB CARABASI MH REICH L COLLINS NH OREILLY RJ
Citation: S. Mackinnon et al., ADOPTIVE IMMUNOTHERAPY USING DONOR LEUKOCYTES FOLLOWING BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA - IS T-CELL DOSE IMPORTANTIN DETERMINING BIOLOGICAL RESPONSE, Bone marrow transplantation, 15(4), 1995, pp. 591-594
ADOPTIVE IMMUNOTHERAPY EVALUATING ESCALATING DOSES OF DONOR LEUKOCYTES FOR RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER BONE-MARROW TRANSPLANTATION - SEPARATION OF GRAFT-VERSUS-LEUKEMIA RESPONSES FROM GRAFT-VERSUS-HOST DISEASE
Authors: MACKINNON S PAPADOPOULOS EB CARABASI MH REICH L COLLINS NH BOULAD F CASTROMALASPINA H CHILDS BH GILLIO AP KERNAN NA SMALL TN YOUNG JW OREILLY RJ
Citation: S. Mackinnon et al., ADOPTIVE IMMUNOTHERAPY EVALUATING ESCALATING DOSES OF DONOR LEUKOCYTES FOR RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER BONE-MARROW TRANSPLANTATION - SEPARATION OF GRAFT-VERSUS-LEUKEMIA RESPONSES FROM GRAFT-VERSUS-HOST DISEASE, Blood, 86(4), 1995, pp. 1261-1268
LONG-TERM FOLLOW-UP OF RECIPIENTS OF HLA-MATCHED RELATED BONE-MARROW TRANSPLANTS DEPLETED OF T-CELLS BY SOYBEAN LECTIN AGGLUTINATION COMBINED WITH AIS CELLECTORS
Authors: CARABASI MH COLLINS NH SMALL TN CASTROMALASPINA H CHILDS BH MACKINNON S PAPADOPOULOS EB YOUNG JW LEBKOWSKI J OKARMA T VANHOEF M BLACK P OREILLY R
Citation: Mh. Carabasi et al., LONG-TERM FOLLOW-UP OF RECIPIENTS OF HLA-MATCHED RELATED BONE-MARROW TRANSPLANTS DEPLETED OF T-CELLS BY SOYBEAN LECTIN AGGLUTINATION COMBINED WITH AIS CELLECTORS, Blood, 86(10), 1995, pp. 366-366
LINEAGE DIVERGENT CLONAL RESTORATION OF HEMATOPOIESIS AFTER SUCCESSFUL ALLOGENIC MARROW TRANSPLANTATION (BMT)
Authors: LIU Y CARABASI MH VAUGHAN WP COOPER MD PRCHAL JT
Citation: Y. Liu et al., LINEAGE DIVERGENT CLONAL RESTORATION OF HEMATOPOIESIS AFTER SUCCESSFUL ALLOGENIC MARROW TRANSPLANTATION (BMT), Blood, 86(10), 1995, pp. 394-394
IMPACT OF THIOTEPA AND DONOR LYMPHOCYTE INFUSIONS ON OUTCOME AFTER T-CELL-DEPLETED (TCD) ALLOGENEIC BMT IN PATIENTS WITH CHRONIC PHASE (CP)CML
Authors: CARABASI MH CASTROMALASPINA H CHILDS BH PAPADOPOULOS EB YOUNG JW COLLINS NH BLACK P OREILLY RJ
Citation: Mh. Carabasi et al., IMPACT OF THIOTEPA AND DONOR LYMPHOCYTE INFUSIONS ON OUTCOME AFTER T-CELL-DEPLETED (TCD) ALLOGENEIC BMT IN PATIENTS WITH CHRONIC PHASE (CP)CML, Blood, 86(10), 1995, pp. 2246-2246
DONOR LEUKOCYTE INFUSIONS FOR MOLECULAR OR CYTOGENETIC RELAPSE OF CMLFOLLOWING ALLOGENEIC BMT - GRAFT-VERSUS-LEUKEMIA RESPONSES WITH MINIMAL TOXICITY
Authors: MACKINNON S PAPADOPOULOS EB CARABASI MH REICH L COLLINS NH BOULAD F CASTROMALASPINA H CHILDS B GILLIO A KERNAN NA SMALL T YOUNG J OREILLY RJ
Citation: S. Mackinnon et al., DONOR LEUKOCYTE INFUSIONS FOR MOLECULAR OR CYTOGENETIC RELAPSE OF CMLFOLLOWING ALLOGENEIC BMT - GRAFT-VERSUS-LEUKEMIA RESPONSES WITH MINIMAL TOXICITY, Blood, 86(10), 1995, pp. 2251-2251
INFUSIONS OF DONOR LEUKOCYTES TO TREAT EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: PAPADOPOULOS EB LADANYI M EMANUEL D MACKINNON S BOULAD F CARABASI MH CASTROMALASPINA H CHILDS BH GILLIO AP SMALL TN YOUNG JW KERNAN NA OREILLY RJ
Citation: Eb. Papadopoulos et al., INFUSIONS OF DONOR LEUKOCYTES TO TREAT EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOPROLIFERATIVE DISORDERS AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATION, The New England journal of medicine, 330(17), 1994, pp. 1185-1191
IMPROVED DISEASE-FREE SURVIVAL IN RECIPIENTS OF T CELL-DEPLETED (SBA-E-) BONE-MARROW ALLOGRAFTS FOR ACUTE NONLYMPHOCYTIC LEUKEMIA IN 1ST REMISSION
Authors: PAPADOPOULOS EB BOULAD F CARABASI MH CASTROMALASPINA H CHILDS BH COLLINS NH EMANUEL D GILLIO AP KERNAN NA MACKINNON S SMALL TN LINDSLEY K YAHALOM J BLEAU S BLACK P HELLER G OREILLY RJ YOUNG JW
Citation: Eb. Papadopoulos et al., IMPROVED DISEASE-FREE SURVIVAL IN RECIPIENTS OF T CELL-DEPLETED (SBA-E-) BONE-MARROW ALLOGRAFTS FOR ACUTE NONLYMPHOCYTIC LEUKEMIA IN 1ST REMISSION, Blood, 84(10), 1994, pp. 10000331-10000331
ADOPTIVE IMMUNOTHERAPY USING ESCALATING DOSES OF DONOR LEUKOCYTES FORRELAPSED CHRONIC MYELOID-LEUKEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: MACKINNON S PAPADOPOULOS EB CARABASI MH REICH L COLLINS NH BOULAD F CASTROMALASPINA H CHILDS B GILLIO A KERNAN NA SMALL T YOUNG J OREILLY RJ
Citation: S. Mackinnon et al., ADOPTIVE IMMUNOTHERAPY USING ESCALATING DOSES OF DONOR LEUKOCYTES FORRELAPSED CHRONIC MYELOID-LEUKEMIA FOLLOWING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 84(10), 1994, pp. 10000538-10000538
RAPID PLATELET RECOVERY-TIME FOLLOWING HIGH-DOSE CHEMOTHERAPY (HDT) FOR METASTATIC BREAST-CANCER SUPPORTED BY HEMATOPOIETIC STEM-CELLS COLLECTED FROM BLOOD (BSC) AFTER G-CSF ADMINISTRATION
Authors: GEILS GF TILDEN AB CARABASI MH FRIEDBERG RC VAUGHAN WP
Citation: Gf. Geils et al., RAPID PLATELET RECOVERY-TIME FOLLOWING HIGH-DOSE CHEMOTHERAPY (HDT) FOR METASTATIC BREAST-CANCER SUPPORTED BY HEMATOPOIETIC STEM-CELLS COLLECTED FROM BLOOD (BSC) AFTER G-CSF ADMINISTRATION, Blood, 84(10), 1994, pp. 10000709-10000709
CHRONIC MYELOGENOUS LEUKEMIA
Authors: CARABASI MH
Citation: Mh. Carabasi, CHRONIC MYELOGENOUS LEUKEMIA, Cancer investigation, 11(4), 1993, pp. 408-419
T-LYMPHOCYTE SIGNALING VIA HLA CLASS-I AND LFA-1 INHIBIT T-LYMPHOCYTERESPONSES TO CD3 PLUS CD28 BY DIFFERENT MECHANISMS
Authors: CARABASI MH ENG WS DUPONT B
Citation: Mh. Carabasi et al., T-LYMPHOCYTE SIGNALING VIA HLA CLASS-I AND LFA-1 INHIBIT T-LYMPHOCYTERESPONSES TO CD3 PLUS CD28 BY DIFFERENT MECHANISMS, Blood, 82(10), 1993, pp. 10000189-10000189
Risultati: 1-18 |